625 - 636 of 7723 results
0.35 CME CREDIT

Join infectious disease specialist, Dr. Daniel Solomon, in the last episode of a 3-part podcast series, as he discusses important concepts related to influenza that are especially relevant in 2020 during the COVID pandemic. During this episode, he will answer frequently asked questions that are compiled from previous Pri-Med activities on the topic of influenza. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 10/13/2020 and they are subject to change as new information is published.


0.33 CME CREDIT

Join pulmonologist Emily Wan, MD as she answers the most pressing questions regarding the management of COPD. In this podcast, Dr. Wan will discuss topics such as when to step-up and step-down therapy, the role of eosinophil count in acute exacerbations, strategies for educating patients on correct inhaler technique (hint – don’t forget about the pharmacist!), how COVID-19 has impacted the management of COPD, and more.


healthcare provider counselling a person with obesity
0.25 CME CREDIT

Traversing the Chasm: Overcoming Challenges of Obesity Management in Primary Care: Module 2

An Interactive Learning Experience from AmplifireThis course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.25 CME/MOC
0.25 AANP | 0.25 Pharmacology

Obesity is a growing epidemic in the United States, and effective treatment of this chronic disease requires evidence-based implementation of treatment approaches. This activity will discuss best practices for approaching the person with obesity and individualizing obesity treatment plans. It will include weight loss pharmacotherapy and approaches to address and overcome barriers to weight loss.


0.5 CME CREDIT

Jeopardy! GLP-1 RA Edition

0.50 CME
0.41 AANP | 0.41 Pharmacology

Think you know it all about GLP-1 receptor agonists? Test your familiarity with these dynamic diabetes drugs in Jeopardy game show. This interactive game will allow you to showcase your knowledge on GLP-1 RA pharmacodynamics, clinical indications, cardiovascular benefits, and more. There will be a rationale following each question, ensuring that you have answers to take back to your practice. Please note that any data, indications, and guidelines presented in this activity are current as of 08/14/20 and they are subject to change as new information is published.


0.25 CME CREDIT

Increasingly, patients are approaching their clinicians with questions about cannabis products. This webcast aims to answer these common questions including the difference between cannabis products that are FDA-approved compared to those that are not, and what conditions have evidence and approvals for the use of cannabinoids. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 11/11/2020 and they are subject to change as new information is published.


1 CME CREDIT

This program provides a perspective on the ever-changing management of patients with COVID-19. It features case studies to encourage retention of the lessons and provide new perspectives on the management of patients during the COVID-19 pandemic. This program will focus on optimizing outcomes for hospitalized and non-hospitalized patients with COVID-19 through the use of novel agents authorized for emergency use.


CDC Resource: HIV in the Southern United States

CDC Resources for Health Care Providers

CDC Resources for Health Care Providers


CDC Resources for Health Care Providers


Nurse explaining the use of diabetic equipment to a patient
0.5 CME CREDIT

Time to meet your new patient! In this interactive activity, you will be guided through the case of a patient with type 2 diabetes at high-risk for atherosclerotic cardiovascular disease (ASCVD) via a series of questions and complementary videos. Questions will test your strengths and weaknesses around diabetes management, with some questions and feedback tailored directly to your management choices. After each question, you will be presented with learning moments designed to help increase your confidence managing patients with type 2 diabetes and reducing cardiovascular risk.


0.5 CME CREDIT

Your patient is ready for you! In this interactive activity, you will be guided through the case of a patient with COPD via a series of questions and complementary videos. Questions will test your strengths and weaknesses around COPD management, with some questions and feedback tailored directly to your management choices. After each question, you will be presented with learning moments designed to help increase your confidence managing patients with COPD and reducing risk of COPD exacerbations. Please note that any data, indications, and guidelines presented in this activity are current as of 10/1/2020 and they are subject to change as new information is published.


1 CME CREDIT

Fight COVID-19 in Outpatient Settings With Neutralizing mAbs

1.00 CME/MOC
1.00 AANP | 1.00 Pharmacology

Neutralizing monoclonal antibodies (mAbs) first received emergency use authorization (EUA) in November 2020 for treating at-risk patients with COVID-19--and the field has continued to evolve ever since. This presentation provides an update in the latest evidence showing reduced severe illness and hospitalization in patients treated with neutralizing mAbs. The expert presenters will explain the science and practical issues of using mAbs to treat patients with COVID-19 in outpatient and skilled nursing facility settings while also answering your questions from their multidisciplinary perspectives. This educational activity includes: • Best practices for identifying appropriate patients for mAb infusions and connecting these patients with infusion therapy • Overview of clinical trial data for efficacy and safety of treatment with neutralizing mAbs alone and in combination with other mAbs • Frontline stories of establishing mAbs infusion programs, including preparing, administering, monitoring, and reporting • Discussion of issues identified through analysis of responses to a survey conducted with Pri-Med learners